Zimmer Biomet Holdings revenue and financials
$89.68Change from previous close: −2.06%Absolute change: −$1.89
In the fiscal year ended December 2025, Zimmer Biomet Holdings reported revenue of $8.23B (+7.20% year over year). Net income was $705.1M, a net margin of 8.6%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +7.20%
- 2025 vs 2024
- Net income growth
- −21.98%
- 2025 vs 2024
- Net margin
- 8.6%
- 2024: 11.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,697 | 1,499 | 1,582 | 1,356 | 1,499 | 1,205 | 1,586 | 1,747 | 1,582 | 1,632 |
| Depreciation and amortization | 1,094 | 996 | 952 | 926 | 938 | 898 | 1,006 | 1,041 | 1,063 | 1,039 |
| Capital expenditure | -225 | -204 | -291 | -188 | -144 | -112 | -207 | -163 | -156 | -185 |
| Investing cash flow | -1,976 | -888 | -779 | -529 | -504 | — | — | — | — | — |
| Financing cash flow | 326 | -485 | -764 | -844 | -1,306 | — | — | — | — | — |
| Dividends paid | -190 | -196 | -201 | -201 | -200 | -199 | -197 | -195 | -194 | -188 |
| Share repurchases | -487 | -868 | -692 | -126 | — | — | — | — | — | -416 |
| Debt issued | 2,492 | 1,436 | 500 | 458 | 1,600 | — | — | — | — | — |
| Debt repaid | -1,463 | -900 | -445 | -1,519 | -2,655 | — | — | — | — | — |
| Effect of exchange rates | 19.0 | -17.1 | 0.9 | -14.5 | -13.2 | — | — | — | — | — |
| Net change in cash | 66.4 | 110 | 40.1 | -103 | -324 | — | — | — | — | — |
| Free cash flow | 1,172 | 1,055 | 979 | 839 | 1,082 | — | — | — | — | — |
| Levered free cash flow | 1,352 | 1,061 | 1,125 | 1,654 | 892 | — | — | — | — | — |